PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 76 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $86,000 | +36.5% | 10,000 | 0.0% | 0.06% | +63.9% |
| Q3 2016 | $63,000 | +50.0% | 10,000 | 0.0% | 0.04% | +50.0% |
| Q2 2016 | $42,000 | -4.5% | 10,000 | 0.0% | 0.02% | -17.2% |
| Q1 2016 | $44,000 | -27.9% | 10,000 | 0.0% | 0.03% | -9.4% |
| Q4 2015 | $61,000 | +7.0% | 10,000 | 0.0% | 0.03% | +28.0% |
| Q3 2015 | $57,000 | -24.0% | 10,000 | 0.0% | 0.02% | -19.4% |
| Q2 2015 | $75,000 | +33.9% | 10,000 | -23.1% | 0.03% | +14.8% |
| Q2 2014 | $56,000 | +5.7% | 13,000 | 0.0% | 0.03% | -3.6% |
| Q1 2014 | $53,000 | -23.2% | 13,000 | 0.0% | 0.03% | -30.0% |
| Q4 2013 | $69,000 | +6.2% | 13,000 | 0.0% | 0.04% | -4.8% |
| Q3 2013 | $65,000 | – | 13,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
| Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
| BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
| Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
| TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
| SEARLE & CO. | 60,000 | $349,000 | 0.34% |
| TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
| Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
| TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |